Status:
COMPLETED
Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Non-Hodgkin's Lymphoma
Autologous Transplantation
Eligibility:
All Genders
Brief Summary
This is a long-term observational study of patients that were treated with at least 1 dose of study treatment (plerixafor or placebo) in the AMD3100-3101 protocol (NCT00103610).
Detailed Description
This is a long-term observational study of patients who received at least one dose of study treatment (plerixafor or placebo) in a multicenter, randomized, double blind, placebo-controlled investigati...
Eligibility Criteria
Inclusion
- All patients who received a dose of study treatment (plerixafor or placebo)in protocol AMD3100-3101 (NCT00103610)
Exclusion
- No Exclusion Criteria
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT00741325
Start Date
June 1 2006
End Date
November 1 2011
Last Update
February 11 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.